Wegovy, Ozempic added to list of drugs where the federal government will try winning discounts from manufacturers.

UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

UnitedHealth Q4 earnings beat EPS estimates at $6.81 but missed revenue projections. Analysts highlight growth potential in ...

As government scrutiny and enforcement targeting the Medicare Advantage (Medicare Part C) program continued in 2024, the ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

Analyst Joanna Gajuk of Bank of America Securities maintained a Buy rating on UnitedHealth (UNH – Research Report), reducing the price target ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

The Department of Justice (DOJ) recouped more than $2.9 billion for the federal government from False Claims Act settlements ...

Healthcare fraud investigations accounted for more than half of the Department of Justice's settlements and judgments in 2024 ...